1. Behzadpour M, Khanjani N. The prevalence of different human immunodeficiency virus transmission routes and knowledge about AIDS in infected people with HIV in Sirjan. J Fasa Univ Med Sci 2012;2(1):45-52. (Persian) [
Google Scholar]
2. van Andel E, Been SK, Rokx C, Rokx C, Vanderend M. Risk factors in an HIV-infected population for refraining from specialist care. J Psychol Sociomed Asp AIDS/HIV 2016; 28(10):1255-60. [
DOI:10.1080/09540121.2016.1168914] [
PMID]
3. Potthoff A, Brockmeyer NH. Status of HIV infections 2005. Herz 2005;30(6):451-7. [
DOI:10.1007/s00059-005-2737-y] [
PMID]
4. Conner RF, Villarreal LP. AIDS: Science and society. London: Jones & Bartlett Publishers; 2013. [
Google Scholar]
5. Akbari M, Moody K. A review of AIDS and its prevention and treatment. Second National Conference on Biology and Environmental Sciences. Gorgan;2016; 17(4):695-704. (Persian) [
URL]
6. Huber F, Merceron A, Madec Y, Gadio G, About V, Pastre A, et al. High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV. J Nat Lib Med 2017;12(4):e0175740. [
DOI:10.1371/journal.pone.0175740] [
PMID] [
PMCID]
7. Nordentoft PB, Engell-Sørensen T, Jespersen S, Correia FG, Medina C, da SilvaTé D, et al. Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau. J Nat Lib Med 2017;45(2):187-97. [
DOI:10.1007/s15010-016-0949-0] [
PMID]
8. www.euronews.com [
URL]
9. Dargahi F, Amani F, Habibzade S, Ezati M, Sadri Z. Prevalence of HCV, HBV, HIV in blood donors in Ardabil Province. J Q Sci Student 2012; 2(1): 86-97. (Persian) [
URL]
10. Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. J Cur HIV Res 2008; 6(3):257-60. [
DOI:10.2174/157016208784324976] [
PMID]
11. Dokubo EK, Baddeley A, Pathmanathan I, Coggin W, Firth J, Getahun H, et al. Provision of antiretroviral therapy for HIV-positive TB patients--19 countries, sub-Saharan Africa, 2009-2013. J MMWR Morb Mortal Wkly Rep 2014;63(47):1104-7. [
PMID] [
PMCID]
12. Organization, W.H. and S.T. Initiative, Treatment of tuberculosis: guidelines. 2019: World Health Organization. [
Google Scholar]
13. Bahador A. Murray Microbiology. Khosravi Publications. 2013. Bahador A;213. [
URL]
14. de Cherif TK, Schoeman JH, Cleary S, Meintjes GA, Rebe K, Maartens G. Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. J BMC Infect Dis 2009;9:205. [
DOI:10.1186/1471-2334-9-205] [
PMID] [
PMCID]
15. Pawlowski A, Jansson M, Sköld M, Rottenberg M, Kallenius G. Tuberculosis and HIV co-infection. J PLoS Pathog 2012;8(2):1-7. [
DOI:10.1371/journal.ppat.1002464] [
PMID] [
PMCID]
16. Rasoolinejad M, Hadadi A, Hedayat M, Moradmand B, Alijani N. Outcome of TB in HIV patients treated with standard regimen. J Tehran Univ Med 2013;71(7):464-70. (Persian) [
Google Scholar]
17. Padyana M, V.Bhat R, Dinesha M, Nawaz A. HIV-Tuberculosis: A Study of Chest X-Ray Patterns in Relation to CD4 Count. J N Am J Med Sci 2012; 4(5):221-5. [
DOI:10.4103/1947-2714.95904] [
PMID] [
PMCID]
18. Kooi E, Mahayidin M. Pulmonary Tuberculosis in HIV Infection: The Relationship of the Radiographic Appearance to CD4 T-Lymphocytes Count. J Malaysian Med Sci 2001;8(1):34-40. [
PMID] [
PMCID]
19. Jaryal A, Raina R, Sarkar M, Sharma A. Manifestations of tuberculosis in HIV/AIDS patients and its relationship with CD4 count. J Lung India 2011;28(4):263-6. [
DOI:10.4103/0970-2113.85687] [
PMID] [
PMCID]
20. Zhu X, Ma D, Zhang J, Peng J, Qu X, Ji C, et al. Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol 2010;30(2):253-9. [
DOI:10.1007/s10875-009-9353-1] [
PMID]
21. Cochran, William G. "1977Sampling techniques." [
URL]
22. Azimi SH, Sabokbar A, Bairami A, Gharavi M. Prevalence of Human Immunodeficiency Virus (HIV) coinfections among male prisoners in Alborz province. J Gorgan Univ Med Sci 2020.22(2):75-81. (Persian) [
URL]
23. Li-xin R, Xiao X, Jing C, Xin S, Qing J. study of screening methods of MTB/HIV co-infected patients in low TB and AIDS prevalence area. J Chinese Antituberculosis 2021;43(3): 240-247. [
Google Scholar]
24. Mohammadnrzhad E, Jalalmanesh SH, Mahmodi M. Prevalence of tuberculosis in patients with HIV infection with frequent visits. J Fac Nurs Midwifery 2010;12:1-10. (Persian) [
URL]
25. https://www.irna.ir/news/84505212/ [
URL]
26. Keshavarz M, Karbalaie Niya MH, Tavakoli A, Keyvani H, Kachooei Mohagheghi Yaghubi A. A review on different types of Real-time PCR methods and its optimization. J JQUMS.2017;21(3):76-90. [
Google Scholar]
27. Charbonnier F, Calmy A, Janssens J. Tuberculosis and HIV co-infection: a therapeutic challenge. J Nat Center Biotech Info 2011;23(7). 2295-300. [
PMID]
28. Alavi SM. Relative frequency of infections among hospitalized injecting drug user HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003). J Jundishapoor Microbiol 2008;1(1):6-9. (Persian) [
Google Scholar]
29. Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G. Incidence of Tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa. J Acquir Immune Defic Syndr 2018;77(1):93-101. [
DOI:10.1097/QAI.0000000000001560] [
PMID] [
PMCID]
30. Mohammadshahi J, Habibzadeh SH, Hosseinzadeh M, Shahbazzadeghan B. Clinical and Epidemiological Characteristics of Patients with HIV in Ardabil City during 2005-2014. J Ardabil Univ Med Sci 2017;17(2):221-9. (Persian) [
Google Scholar]
31. Fenner L, Atkinson A,Boulle A and et all. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. J Nat Libr Med 2017; 20(1):21327. [
DOI:10.7448/IAS.20.1.21327] [
PMID] [
PMCID]
32. Zerdali E,Yılmaz I, Sürme S, Sayılı U, Yıldırım M. Predictors for tuberculosis co-infection in people living with HIV/AIDS. J Afr Health Sci 2021; 21(3):995-1002. [
DOI:10.4314/ahs.v21i3.6] [
PMID] [
PMCID]